BRA
Bender Robert & Associates Portfolio holdings
AUM
$448M
This Quarter Return
+17.08%
1 Year Return
+20.39%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$427M
AUM Growth
+$427M
(+7.5%)
Cap. Flow
-$8.97M
Cap. Flow
% of AUM
-2.1%
Top 10 Holdings %
Top 10 Hldgs %
72.29%
Holding
50
New
–
Increased
3
Reduced
37
Closed
7
Top Buys
| 1 |
Palo Alto Networks
PANW
|
$221K |
| 2 |
Microsoft
MSFT
|
$209K |
| 3 |
Starbucks
SBUX
|
$28.1K |
Top Sells
| 1 |
Apple
AAPL
|
$1.7M |
| 2 |
NVIDIA
NVDA
|
$1.53M |
| 3 |
Amazon
AMZN
|
$613K |
| 4 |
Intuitive Surgical
ISRG
|
$445K |
| 5 |
Alphabet (Google) Class C
GOOG
|
$376K |
Sector Composition
| 1 | Technology | 44.07% |
| 2 | Consumer Discretionary | 24.89% |
| 3 | Healthcare | 18.09% |
| 4 | Communication Services | 11.33% |
| 5 | Utilities | 0.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
AbbVie
ABBV
$372B
| $1.55M | 0.36% |
8,524
-633
| -7% | -$115K |
|
27
Bristol-Myers Squibb
BMY
$96B
| $1.49M | 0.35% |
27,442
-250
| -0.9% | -$13.6K |
|
28
AstraZeneca
AZN
$248B
| $1.27M | 0.3% |
18,813
-4,365
| -19% | -$296K |
|
29
Costco
COST
$418B
| $1.2M | 0.28% |
1,641
-56
| -3% | -$41K |
|
30
Merck
MRK
$210B
| $879K | 0.21% |
6,663
-60
| -0.9% | -$7.92K |
|
31
Abbott
ABT
$231B
| $775K | 0.18% |
6,817
-317
| -4% | -$36K |
|
32
JPMorgan Chase
JPM
$829B
| $677K | 0.16% |
3,381
-145
| -4% | -$29K |
|
33
Johnson & Johnson
JNJ
$427B
| $663K | 0.16% |
4,189
-412
| -9% | -$65.2K |
|
34
Paychex
PAYX
$50.2B
| $638K | 0.15% |
5,195
-210
| -4% | -$25.8K |
|
35
Nucor
NUE
$34.1B
| $619K | 0.15% |
3,130
-80
| -2% | -$15.8K |
|
36
UroGen Pharma
URGN
$900M
| $521K | 0.12% |
34,701
| – | – |
|
37
Deere & Co
DE
$129B
| $520K | 0.12% |
1,265
-65
| -5% | -$26.7K |
|
38
Caterpillar
CAT
$196B
| $491K | 0.12% |
1,339
-75
| -5% | -$27.5K |
|
39
Boeing
BA
$177B
| $482K | 0.11% |
2,495
-124
| -5% | -$23.9K |
|
40
Oracle
ORCL
$635B
| $300K | 0.07% |
2,389
| – | – |
|
41
Visa
V
$683B
| $289K | 0.07% |
1,037
-5
| -0.5% | -$1.4K |
|
42
Target
TGT
$43.6B
| $257K | 0.06% |
1,450
| – | – |
|
43
Idexx Laboratories
IDXX
$51.8B
| $214K | 0.05% |
397
-25
| -6% | -$13.5K |
|
44
BioCryst Pharmaceuticals
BCRX
$1.74B
| – | – |
-56,600
| Closed | -$339K |
|
45
Duke Energy
DUK
$95.3B
| – | – |
-2,080
| Closed | -$202K |
|
46
Evolus
EOLS
$494M
| – | – |
-25,070
| Closed | -$264K |
|
47
Pfizer
PFE
$141B
| – | – |
-7,755
| Closed | -$223K |
|
48
Pulse Biosciences
PLSE
$1.05B
| – | – |
-10,325
| Closed | -$126K |
|
49
Summit Therapeutics
SMMT
$17.6B
| – | – |
-24,059
| Closed | -$62.8K |
|
|
CMRX
50
DELISTED
Chimerix, Inc.
CMRX
| – | – |
-10,609
| Closed | -$10.2K |
|